The effect of two media, three pH values, and three inoculum densities on the activity of ceftizoxime and Sch-34343 against anaerobic bacteria was evaluated. The activities of both antimicrobial agents were affected by medium composition, especially against Bacteroidesfragilis. Changes in pH and inoculum size affected only the activity of ceftizoxime against anaerobic bacteria.
In the past few years, several new beta-lactam antimicrobial agents have been developed. Among them is ceftizoxime, a desacetoxymethyl derivative of cefotaxime that exhibits a broad spectrum of activity against aerobic bacteria. Its activity against anaerobic bacteria is not well documented, but it appears to be more active than other broad-spectrum cephalosporins (8) . Sch-34343 is a new penem antibiotic which has exhibited good activity against a broad range of gram-positive and gram-negative bacteria (17) .
The purpose of this study was to evaluate the influence of two culture media, three pH values, and three inoculum densities on the activity of these antimicrobial agents against clinical isolates of anaerobic bacteria.
A total of 100 strains, including 50 Bacteroides fragilis group spp. (30 B. fragilis, 7 B. distasonis, 6 B. vulgatus, 4 B. ovatus, and 3 B. thetaiotaomicron), 25 Clostridium spp. (11 C. perfringens, 9 C. bifermentans, 2 C. sordelli, 2 C. beijerinckii, and 1 C. septicum), and 25 Peptostreptococcus spp. (5 P. magnus, 3 P. prevotii, 5 P. asaccharolyticus, 5 P. productus, 4 P. parvulus, and 3 P. anaerobius), were examined. Isolates were identified by the criteria of Holdeman and Moore (9) , and beta-lactamase production was determined for all B. fragilis strains (14) . Four recommended reference strains were used for quality control (16) . Laboratory standards were kindly supplied as follows: ceftizoxime, Smith Kline & French Laboratories, Philadelphia, Pa.; Sch-34343, Schering Corp., Bloomfield, N.J.
MICs were determined by the agar dilution method. Inocula were prepared as described below (16) . Two culture media, Wilkins-Chalgren agar (WC) and brucella agar (BA), were used; both were supplemented with vitamin K1 and hemin. BA was also enriched with 5% laked sheep blood (18) .
The plates were incubated at 35°C in a Coy anaerobic chamber and read after about 48 h of incubation. Chamber quality control included daily tests of temperature (35 ± 2°C), indicator (methylene blue), and inflation, a weekly change of the catalyst, and checks for contamination and growth of Peptostreptococcus anaerobius after 48 h of incubation (12) .
The effect of adjusting the pH to 6, 7, and 8 was determined on WC (2 (17) found the MIC90 of Sch-34343 against B. fragilis group and Peptostreptococcus spp. to be slightly higher, whereas their MIC range against Clostridium spp. was much higher than ours.
In conclusion, both antimicrobial agents showed good activity against anaerobic bacteria. Changes in culture medium, pH, and inoculum size affected ceftizoxime activity, but Sch-34343 generally showed a high stability when susceptibility test conditions were modified. These in vitro results suggest that further studies of the effectiveness of ceftizoxime and Sch-34343 treatment of infections caused by anaerobic bacteria should be undertaken, and it is reasonable to expect that these two antimicrobial agents will be therapeutically useful in treating such infections.
